首页> 美国卫生研究院文献>Cell Regulation >LRRC4 a Putative Tumor Suppressor Gene Requires a Functional Leucine-rich Repeat Cassette Domain to Inhibit Proliferation of Glioma Cells In Vitro by Modulating the Extracellular Signal-regulated Kinase/Protein Kinase B/Nuclear Factor-κB Pathway
【2h】

LRRC4 a Putative Tumor Suppressor Gene Requires a Functional Leucine-rich Repeat Cassette Domain to Inhibit Proliferation of Glioma Cells In Vitro by Modulating the Extracellular Signal-regulated Kinase/Protein Kinase B/Nuclear Factor-κB Pathway

机译:LRRC4一个假定的肿瘤抑制基因需要一个功能丰富的亮氨酸重复盒结构域来通过调节细胞外信号调节激酶/蛋白激酶B /核因子-κB途径来抑制胶质瘤细胞的体外增殖。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We have previously reported that the LRRC4 gene, which contains a conserved leucine-rich repeat (LRR) cassette and an immunoglobulin (Ig) IgC2 domain, is associated with glioma suppression both in vitro and in vivo. The present study provides evidence that the conspicuous absence of LRRC4 in high-grade gliomas directly contributes to the increasing tumor grade. The loss of LRRC4 in U251 cells is caused by the loss of homozygosity at chromosome 7q32-ter. It was also found that LRRC4 requires a functional LRR cassette domain to suppress U251 cell proliferation. In the LRR cassette domain, the third LRR motif of the core LRR is found to be indispensable for the function of LRRC4. The inhibitory effect of LRRC4 is accompanied by a decrease in the expression of pERK, pAkt, pNF-κBp65, signal transducer and activator of transcription protein-3 (STAT3), and mutant p53, and an increase in the expression of c-Jun NH2-terminal kinase (JNK)2 and p-c-Jun, suggesting that LRRC4 plays a major role in suppressing U251 cell proliferation by regulating the extracellular signal-regulated kinase (ERK)/Akt/NF-κBp65, STAT3, and JNK2/c-Jun pathways. In conclusion, LRRC4 may act as a novel candidate of tumor suppressor gene. Therefore, the loss of LRRC4 function may be an important event in the progression of gliomas.
机译:我们以前曾报道过,LRRC4基因,其中包含一个保守的富亮氨酸重复(LRR)盒和一个免疫球蛋白(Ig)IgC2域,在体外和体内均与神经胶质瘤抑制有关。本研究提供证据,在高度神经胶质瘤中明显缺乏LRRC4直接导致肿瘤分级的增加。 U251细胞中LRRC4的丢失是由7q32-ter染色体纯合性的丢失引起的。还发现LRRC4需要功能性的LRR盒结构域来抑制U251细胞增殖。在LRR盒结构域中,发现核心LRR的第三个LRR基序对于LRRC4的功能是必不可少的。 LRRC4的抑制作用伴随着pERK,pAkt,pNF-κBp65,信号转导子和转录蛋白3(STAT3)的激活子以及突变体p53的表达减少,以及c-Jun NH2的表达增加。 -末端激酶(JNK)2和pc-Jun,提示LRRC4通过调节细胞外信号调节激酶(ERK)/ Akt /NF-κBp65,STAT3和JNK2 / c-Jun在抑制U251细胞增殖中起主要作用途径。总之,LRRC4可以作为抑癌基因的新候选者。因此,LRRC4功能的丧失可能是神经胶质瘤进展中的重要事件。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号